Author

Lorenzo Bertani 1

1 University of Pisa,Pisa,Italy

BASELINE IMPEDANCE VALUES CAN REPRESENT A MARKER OF GASTROESOPHAGEAL REFLUX DISEASE AND ARE STRONGLY RELATED WITH THE DURATION OF THE DISEASE.

Nicola de Bortoli, Salvatore Russo, Irene Martinucci, Manuele Furnari, Salvatore Tolone, Lorenzo Bertani, Marzio Frazzoni, Leonardo Frazzoni, Vincenzo Savarino, Santino Marchi, Edoardo Vincenzo Savarino

Early Vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease

Luisa Guidi, Daniela Pugliese, Tommaso Panici Tonucci, Lorenzo Bertani, Francesco Costa, Giuseppe Privitera, Elisa Gremese, Barbara Tolusso, Clara Di Mario, Alfredo Papa, Antonio Gasbarrini, Gian Lodovico Rapaccini, Alessandro Armuzzi

FATIGUE PERCEPTION DURING VEDOLIZUMAB THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES IS ASSOCIATED WITH THERAPEUTIC RESPONSE

Lorenzo Bertani, Domenico Tricò, Federico Zanzi, Francesca Coppini, Gherardo Tapete, Giovanni Baiano Svizzero, Linda Ceccarelli, Maria Gloria Mumolo, Francesco Costa

HIGH RESOLUTION MANOMETRY AND CLINICAL CHARACTERISTICS OF PATIENTS WITH OUTFLOW OBSTRUCTION: IS THIS A TRULY RELEVANT NOVEL MANOMETRIC DIAGNOSIS?

Nicola de Bortoli, Irene Martinucci, Salvatore Russo, Salvatore Tolone, Manuele Furnari, Lorenzo Bertani, Marzio Frazzoni, Leonardo Frazzoni, Massimo Bellini, Vincenzo Savarino, Santino Marchi, Edoardo Vincenzo Savarino

Histomorphological and molecular characterization of Parkinson´s disease patients with chronic constipation: a pilot study

Massimo Bellini, Bernardo Fani, Lorenzo Bertani, Gabriele Bellini, Andrea Pancetti, Matteo Fornai, Chiara Ippolito, Daniela Frosini, Carolina Pellegrini, Dario Gambaccini, Nunzia Bernardini, Roberto Ceravolo, Santino Marchi, Corrado Blandizzi

LOW FODMAP DIET FOR IRRITABLE BOWEL SYNDROME: SOME ANSWERS TO THE DOUBTS FROM A LONG-TERM FOLLOW-UP

Massimo Bellini, Sara Tonarelli, Federico Barracca, Riccardo Morganti, Andrea Pancetti, Lorenzo Bertani, Francesco Rettura, Francesco Bronzini, Francesca Geri, Nicola de Bortoli, Santino Marchi, Alessandra Rossi

Low FODMAP diet in the long term: efficacy, acceptability and individual perception of trigger foods: A pilot study

Massimo Bellini, Lorenzo Bertani, Andrea Pancetti, Sara Tonarelli, Dario Gambaccini, Francesco Costa, Nicola de Bortoli, Riccardo Morganti, Marta Mosca, Santino Marchi, Alessandra Rossi

LOW FODMAP DIET IN THE LONG TERM: EFFICACY, ACCEPTABILITY AND INDIVIDUAL PERCEPTION OF TRIGGER FOODS: A PILOT STUDY

Lorenzo Bertani

NON-MEDICAL SWITCHING FROM REFERENCE ADALIMUMAB TO SB5 BIOSIMILAR: A MULTICENTER REAL LIFE EVIDENCE FROM TUSCANY REGION

Gherardo Tapete, Lorenzo Bertani, Alberto Pieraccini, Erika Lynch, Martina Giannotta, Riccardo Morganti, Ivano Biviano, Sara Naldini, Maria Gloria Mumolo, Francesca De Nigris, Francesca Calella, Siro Bagnoli, moira minciotti, Silvia Rentini, Linda Ceccarelli, Paolo Lionetti, Monica Milla, Francesco Costa

SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY

Linda Cingolani, Brigida Barberio, Fabiana Zingone, Piera Melatti, Lorenzo Bertani, Antonio Ferronato, Alessandro Gubbiotti, Davide Massimi, Cesare Casadei, Greta Lorenzon, Renata D'Incà, Edoardo Vincenzo Savarino

Item 1 - 10 / 16
1
2